Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Curaleaf Holdings, Inc. (CURLF)

Other OTC - Other OTC Delayed Price. Currency in USD
4.3000+0.2500 (+6.17%)
At close: 03:59PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close4.0500
Open3.9500
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range3.9500 - 4.3500
52 Week Range2.1900 - 7.9000
Volume371,711
Avg. Volume631,695
Market Cap3.113B
Beta (5Y Monthly)1.68
PE Ratio (TTM)N/A
EPS (TTM)-0.5400
Earnings DateNov 06, 2023 - Nov 10, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.32
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for CURLF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CURALEAF HOLDINGS INC
    Analyst Report: Curaleaf Holdings, Inc.Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 19 states. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.
    Rating
    Fair Value
    Economic Moat
    24 days agoMorningstar
View more
  • Zacks

    Cannabis Stocks & ETFs: Can the Recent Surge Continue?

    CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.

  • InvestorPlace

    The 3 Best Cannabis Stocks to Buy Now: September 2023

    With cannabis usage continuing to rise, now could be an opportune time to invest in marijuana stocks. Over 52 million Americans currently use cannabis, and legalization seems inevitable as more states approve recreational and medical use. However, investing in cannabis stocks is extremely risky and highly speculative. I’d recommend taking only a small position in most names, as the regulatory environment remains uncertain. Though public opinion has shifted, full federal legalization in the U.S.

  • CNW Group

    Curaleaf Expands Brand Portfolio With Launch of Zero Proof ™ Cannabis-Infused Drinkables

    Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the launch of Zero Proof, a new brand of THC drinkables in fast-acting, sessionable and easy-to-use formats. The brand's inaugural product offering, Squeeze, is now available at all Curaleaf locations in Illinois and will be followed by additional SKUs in the coming months.

Advertisement
Advertisement